Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites
- PMID: 11485553
- PMCID: PMC1222033
- DOI: 10.1042/0264-6021:3580069
Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites
Abstract
The enzymic activity of the mammalian pyruvate dehydrogenase complex is regulated by the phosphorylation of three serine residues (sites 1, 2 and 3) located on the E1 component of the complex. Here we report that the four isoenzymes of protein kinase responsible for the phosphorylation and inactivation of pyruvate dehydrogenase (PDK1, PDK2, PDK3 and PDK4) differ in their abilities to phosphorylate the enzyme. PDK1 can phosphorylate all three sites, whereas PDK2, PDK3 and PDK4 each phosphorylate only site 1 and site 2. Although PDK2 phosphorylates site 1 and 2, it incorporates less phosphate in site 2 than PDK3 or PDK4. As a result, the amount of phosphate incorporated by each isoenzyme decreases in the order PDK1>PDK3>or=PDK4>PDK2. Significantly, binding of the coenzyme thiamin pyrophosphate to pyruvate dehydrogenase alters the rates and stoichiometries of phosphorylation of the individual sites. First, the rate of phosphorylation of site 1 by all isoenzymes of kinase is decreased. Secondly, thiamin pyrophosphate markedly decreases the amount of phosphate that PDK1 incorporates in sites 2 and 3 and that PDK2 incorporates in site 2. In contrast, the coenzyme does not significantly affect the total amount of phosphate incorporated in site 2 by PDK3 and PDK4, but instead decreases the rate of phosphorylation of this site. Furthermore, pyruvate dehydrogenase complex phosphorylated by the individual isoenzymes of kinase is reactivated at different rates by pyruvate dehydrogenase phosphatase. Both isoenzymes of phosphatase (PDP1 and PDP2) readily reactivate the complex phosphorylated by PDK2. When pyruvate dehydrogenase is phosphorylated by other isoenzymes, the rates of reactivation decrease in the order PDK4>or=PDK3>PDK1. Taken together, results reported here strongly suggest that the major determinants of the activity state of pyruvate dehydrogenase in mammalian tissues include the phosphorylation site specificity of isoenzymes of kinase in addition to the absolute amounts of kinase and phosphatase protein expressed in mitochondria.
Similar articles
-
Interaction between the individual isoenzymes of pyruvate dehydrogenase kinase and the inner lipoyl-bearing domain of transacetylase component of pyruvate dehydrogenase complex.Biochem J. 2002 Aug 15;366(Pt 1):129-36. doi: 10.1042/BJ20020301. Biochem J. 2002. PMID: 11978179 Free PMC article.
-
Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase.J Biol Chem. 2001 Oct 5;276(40):37223-9. doi: 10.1074/jbc.M103069200. Epub 2001 Aug 2. J Biol Chem. 2001. PMID: 11486000
-
Diversity of the pyruvate dehydrogenase kinase gene family in humans.J Biol Chem. 1995 Dec 1;270(48):28989-94. doi: 10.1074/jbc.270.48.28989. J Biol Chem. 1995. PMID: 7499431
-
Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia.Curr Drug Targets Immune Endocr Metabol Disord. 2002 Jul;2(2):151-65. Curr Drug Targets Immune Endocr Metabol Disord. 2002. PMID: 12476789 Review.
-
Regulation of mammalian pyruvate dehydrogenase complex by phosphorylation: complexity of multiple phosphorylation sites and kinases.Exp Mol Med. 2001 Dec 31;33(4):191-7. doi: 10.1038/emm.2001.32. Exp Mol Med. 2001. PMID: 11795479 Review.
Cited by
-
Stoichiometry and architecture of the human pyruvate dehydrogenase complex.Sci Adv. 2024 Jul 19;10(29):eadn4582. doi: 10.1126/sciadv.adn4582. Epub 2024 Jul 17. Sci Adv. 2024. PMID: 39018392 Free PMC article.
-
SIRT5 functions as a tumor suppressor in renal cell carcinoma by reversing the Warburg effect.J Transl Med. 2021 Dec 20;19(1):521. doi: 10.1186/s12967-021-03178-6. J Transl Med. 2021. PMID: 34930316 Free PMC article.
-
Monitoring phosphorylation of the pyruvate dehydrogenase complex.Anal Biochem. 2009 Jun 15;389(2):157-64. doi: 10.1016/j.ab.2009.03.040. Epub 2009 Mar 31. Anal Biochem. 2009. PMID: 19341700 Free PMC article.
-
Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease.J Neurosci. 2017 Mar 8;37(10):2776-2794. doi: 10.1523/JNEUROSCI.2006-14.2016. Epub 2017 Jan 25. J Neurosci. 2017. PMID: 28123081 Free PMC article.
-
The Implications of PDK1-4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance.Front Oncol. 2020 Dec 15;10:583217. doi: 10.3389/fonc.2020.583217. eCollection 2020. Front Oncol. 2020. PMID: 33384955 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous